LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis — Stella

Recruiting

Back to Methamphetamine Use Disorder trials

Trial locations(1 site)

Turkey (Türkiye)

Elazığ Mental Health and Diseases Hospital, Elâzığ, Elâzığ

Key details

Sponsor

Elazığ Mental Health and Diseases Hospital

Enrollment target

~120 participants

Started

September 2025

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 49 Years

Sex

Male only

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov